Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 0.8× sales vs its 0.6× historical median P/S.
Fair value ≈ $0.18 · price $0.25 today
Overvalued · 37% above
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$NVLPF Starting to emerge from a huge multi-year base. New tangential biz units announced, key hires, & dry powder for more acquisitions. 2026 will be a standout year for Chris and the Nova Leap Team
$NVLPF I've been sizing this up. Today's microcap presentation reiterated that 2026 will be the best year for the company ever. Labor headwinds mitigated, and more cash than ever for deals. I wouldn't bet against Chris or the multitude of insider buys at these prices
$NVLPF ranks among Canada's top companies and the TSX Venture 50. Focused on elderly care, especially dementia care, NLH capitalizes on the growing demand for home care services amid aging populations. Despite revenue fluctuations, the company achieved consecutive record quarters and plans to resume acquisitions in 2024, highlighting growth potential for investors.
$NVLPF [15s. delayed]: Issued Press Release on August 23, 16:30:00: Nova Leap Health Corp. Announces Non-Brokered Private Placement of Com https://s.flashalert.me/6Dpfn
